TD Asset Management »

Verve Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $656k 47k 13.94
2023-09-30 $412k 31k 13.26
2023-06-30 $582k 31k 18.75
2023-03-31 $448k 31k 14.42
2022-12-31 $481k 25k 19.35
2022-09-30 $463k 14k 34.19